Literature DB >> 18794608

Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.

Ferran Cereto1, Xavier Herranz, Eva Moreno, Antònia Andreu, Mertxe Vergara, Dionisia Fontanals, Mercè Roget, Maria Simó, Antonio González, Guillem Prats, Joan Genescà.   

Abstract

OBJECTIVES: Host factors and bacterial virulence determinants may play a role in Escherichia coli (E. coli) spontaneous bacterial peritonitis. We evaluated the importance of these factors in the emergence of fluoroquinolone-resistant strains and outcome in cirrhotic patients with E. coli spontaneous bacterial peritonitis.
METHODS: E. coli spontaneous bacterial peritonitis was detected in a 2-year period in three tertiary hospitals. Clinical and bacteriological data were obtained. Phylogenetic group and 15 virulence genes of E. coli strains were analyzed by polymerase gene reaction and compared with 50 isolates from pyelonephritis patients.
RESULTS: Forty-seven E. coli spontaneous bacterial peritonitis patients were identified, 18 (38%) were fluoroquinolone-resistant, a 12% increase compared with our earlier series from 1997 to 2002. Fluoroquinolone resistance was associated with norfloxacin prophylaxis, increased resistance to trimethoprim-sulfamethoxazole and cefotaxime, and less bacterial virulence, as demonstrated by a higher prevalence of 'nonpathogenic' phylogenetic groups A+B1 (56 vs. 28%; P=0.04) and lower virulence scores in fluoroquinolone-resistant E. coli compared with fluoroquinolone-susceptible E. coli. E. coli strains from cirrhotic patients belonged more frequently to 'nonpathogenic' phylogenetic groups A+B1, had fewer virulence factors and higher rates of fluoroquinolone resistance than isolates from pyelonephytis patients. Immunosuppression was independently associated with in-hospital and 3-month mortality. Bacterial virulence factors were unrelated to mortality.
CONCLUSION: Fluoroquinolone-resistant E. coli spontaneous bacterial peritonitis prevalence is increasing because of norfloxacin prophylaxis. Strains from peritonitis are less virulent than strains from pyelonephritis because of a higher prevalence of A+B1 phylogeny and quinolone resistance. Mortality is related to immunosuppression, but not to bacterial virulence factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794608     DOI: 10.1097/MEG.0b013e3282fc7390

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease.

Authors:  Archita P Desai; Nancy Reau; K Gautham Reddy; Helen S Te; Smruti Mohanty; Rohit Satoskar; Amanda Devoss; Donald Jensen
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

2.  Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-12-08       Impact factor: 11.382

3.  The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications.

Authors:  Juan Acevedo; Aníbal Silva; Verónica Prado; Javier Fernández
Journal:  Hepatol Int       Date:  2012-08-14       Impact factor: 6.047

4.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

5.  Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.

Authors:  Alexandra Alexopoulou; Larisa Vasilieva; Danai Agiasotelli; Kyriaki Siranidi; Sophia Pouriki; Athanasia Tsiriga; Marina Toutouza; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 6.  Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis.

Authors:  M C MacKinnon; J M Sargeant; D L Pearl; R J Reid-Smith; C A Carson; E J Parmley; S A McEwen
Journal:  Antimicrob Resist Infect Control       Date:  2020-12-10       Impact factor: 4.887

7.  Treatment of Hospital-Acquired Infections in Patients with Cirrhosis - New Challenges.

Authors:  Dadasaheb G Maindad; Suresh Shenoy; Suchitra Shenoy; Sandeep Gopal; Bailuru Vishwanath Tantry
Journal:  Infect Drug Resist       Date:  2022-03-15       Impact factor: 4.003

8.  PREVALENCE OF BACTERIAL RESISTANCE IN HOSPITALIZED CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL: A NEW CHALLENGE.

Authors:  Ane Micheli Costabeber; Angelo Alves de Mattos; Teresa Cristina Teixeira Sukiennik
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-05-24       Impact factor: 1.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.